Daratumumab utilization and cost analysis among patients with multiple myeloma in a US community oncology setting

MLA

Neil Nagovski, et al. “Daratumumab Utilization and Cost Analysis among Patients with Multiple Myeloma in a US Community Oncology Setting.” Future Oncology (London, England), vol. 18, no. 3, Oct. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d63f42185274be9eec075d9f50df4739&authtype=sso&custid=ns315887.

APA

Neil Nagovski, J Hunter Lambert, Lucio N. Gordan, Stanley M. Marks, Robert E. Smith, & Mei Xue. (2021). Daratumumab utilization and cost analysis among patients with multiple myeloma in a US community oncology setting. Future Oncology (London, England), 18(3).

Chicago

Neil Nagovski, J Hunter Lambert, Lucio N. Gordan, Stanley M. Marks, Robert E. Smith, and Mei Xue. 2021. “Daratumumab Utilization and Cost Analysis among Patients with Multiple Myeloma in a US Community Oncology Setting.” Future Oncology (London, England) 18 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d63f42185274be9eec075d9f50df4739&authtype=sso&custid=ns315887.